Related Experiment Video
Updated: Jul 18, 2026

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
Published on: November 3, 2023
Coagulopathy in pediatric abusive head trauma
K P Hymel1, T C Abshire, D W Luckey
1Department of Pediatrics, School of Medicine, University of Colorado Health Sciences Center, Denver, USA.
Insights
Coagulopathy, including prothrombin time (PT) prolongation and activated coagulation, is frequent in pediatric abusive head trauma. Parenchymal brain damage significantly increases the likelihood of these coagulation defects.
Area of Science:
- Pediatric Traumatology
- Hematology
- Neurology
Background:
- Coagulopathy can be a complication of head trauma, potentially linked to parenchymal brain damage.
- Abusive head trauma (AHT) in children presents unique diagnostic challenges.
Purpose of the Study:
- To determine the frequency of coagulation defects in pediatric AHT.
- To investigate the association between coagulation abnormalities and parenchymal brain damage in AHT.
Main Methods:
- Retrospective review of 147 pediatric patients hospitalized for head trauma with validated AHT and coagulation screening within 48 hours.
- Nonparametric analysis comparing coagulation test results between patients with and without parenchymal brain damage.
Main Results:
- Prothrombin time (PT) prolongation occurred in 54% of AHT patients with parenchymal brain damage versus 20% without.
- Among deceased AHT patients with parenchymal brain damage, 94% had PT prolongation and 63% showed activated coagulation.
- Coagulation abnormalities are common in pediatric AHT, particularly with parenchymal brain damage.
Conclusions:
- PT prolongation and activated coagulation are frequent complications of pediatric AHT.
- In AHT with parenchymal brain damage, coagulation abnormalities are unlikely to be due to pre-existing conditions.
- Findings have implications for diagnosis, prognosis, and legal considerations in pediatric abusive head trauma cases.
Objectives:
Coagulopathy is a potential complication of head trauma that may be attributable to parenchymal brain damage. The objectives of this study were to assess the frequency of coagulation defects in pediatric abusive head trauma and to analyze their relationship to parenchymal brain damage.
Methods:
We reviewed the records of 265 pediatric patients hospitalized for head trauma. One hundred forty-seven patients met study inclusion criteria: (1) radiologic evidence of head trauma, (2) multidisciplinary validation that head trauma had been inflicted, and (3) coagulation screening performed within 2 days of presentation. Using nonparametric analysis, initial coagulation test results were compared between study patients without parenchymal brain damage and those with parenchymal brain damage.
Results:
Mild prothrombin time (PT) prolongations (median 13.1) occurred in 54% of study patients with parenchymal brain damage and only 20% of study patients without parenchymal brain damage. Among pediatric abusive head trauma patients with parenchymal brain damage who died, 94% displayed PT prolongations (median 16.3) and 63% manifested evidence of activated coagulation.
Conclusions:
PT prolongation and activated coagulation are common complications of pediatric abusive head trauma. In the presence of parenchymal brain damage, it is highly unlikely that these coagulation abnormalities reflect a preexisting hemorrhagic diathesis. These conclusions have diagnostic, prognostic, and legal significance.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Traumatic Brain Injury l: Introduction
Increased Intracranial Pressure l: Introduction
Cerebral Edema ll: Pathophysiology

